Think of Xydalba as Similar to Vancomycin for Resistant Skin Infections

Xydalba (dalbavancin) will be a new IV antibiotic for skin infections.

It's a cousin of vancomycin and is bactericidal against gram-positives...such as methicillin-resistant Staphylococcus aureus (MRSA).

But Xydalba is given as a SINGLE dose or in 2 divided doses one week apart...since it has a long half-life. Vancomycin is usually given twice daily for 7 to 14 days.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote